Shanghai Institute of Materia Medica (SIMM)
Chinese Academy of Sciences
555 Zu Chong Zhi Road
Shanghai
201203
China
Tel: 0086-21-50806600
Fax: 0086-21-50807088
Website: http://www.simm.ac.cn/
Email: suoban@mail.shcnc.ac.cn
10 articles about Shanghai Institute of Materia Medica (SIMM)
-
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments
11/23/2021
On November 17, 2021, Simcere Pharmaceutical Group Limited announced that the company has reached collaboration agreement with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, to develop novel antiviral drugs for COVID-19.
-
Agilent Presents Thought Leader Award to Professor Hualiang Jiang
9/19/2019
Chinese Academy of Sciences scientist recognized for his work in medicinal chemistry and drug discovery
-
Shanghai Institute of Materia Medica: Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery
1/4/2018
Recently, scientists at SIMM determined the crystal structure of GCGR in complex with a glucagon analogue and partial agonist NNC1702.
-
Shanghai Institute of Materia Medica And Crown Bioscience, Inc. To Collaborate On Cancer Center In China
11/27/2013
-
Shanghai Institute of Materia Medica and Servier Collaborate on China Development for Cancer Drug
9/17/2013
-
Fosun Pharma and Shanghai Institute of Materia Medica to Co-Develop Oncology Drug
11/27/2012
-
Shanghai Institute of Materia Medica, Jilin University and University of Bradford Project Seeks to Improve TCM Treatment for Malaria
10/8/2010
-
Oslo Cancer Cluster and Shanghai Institute of Materia Medica Sign Groundbreaking MoU to Form Third Pillar of Global Biosciences Gateway
9/16/2010
-
Servier Collaborates with Shanghai Institute of Materia Medica on Cancer Drug Discovery
10/15/2009
-
HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
10/2/2007